Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 13/20 | 1.00 |
| ▸ | CDK5R1 | Q15078 | 13/20 | 1.00 |
| ▸ | CCNA2 | P20248 | 10/20 | 1.00 |
| ▸ | CDK2 | P24941 | 10/20 | 1.00 |
| ▸ | CCNA1 | P78396 | 10/20 | 1.00 |
| ▸ | DYRK1A | Q13627 | 9/20 | 1.00 |
| ▸ | CDK1 | P06493 | 8/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | CCNB1 | P14635 | 4/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | CCNB2 | O95067 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Purvalanola SCHEMBL29360281 | 1.00 | CDK5 (1.00) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| Purvalanola SCHEMBL1217069 | 1.00 | CDK5 (1.00) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| Purvalanola SCHEMBL3311119 | 1.00 | CDK5 (1.00) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| Aminopurvalanol SCHEMBL2170683 | 0.87 | CDK1 (1.00) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| Aminopurvalanol SCHEMBL29386084 | 0.87 | CDK1 (1.00) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| Aminopurvalanol SCHEMBL23752328 | 0.87 | CDK1 (1.00) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| Aminopurvalanol SCHEMBL21168739 | 0.87 | CDK1 (1.00) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL13638193 | 0.86 | CDK5 (0.76) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL7526656 | 0.85 | CDK1 (0.82) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL20694113 | 0.85 | CDK5 (0.77) | CDK5CDK5R1CCNA2CDK2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197874-A1 | PLANT-PRODUCED CHIMAERIC ORBIVIRUS VLPS | CSIR (ZA) | 2025-06-19 | — | — | US | disclosed |
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | UNIVERSITY OF WASHINGTON | 2025-04-03 | — | — | US | disclosed |
| US-20250043276-A1 | Targeted Enrichment of Nucleic Acid Sequences | UNIVERSITY OF OREGON | 2025-02-06 | — | — | US | disclosed |
| US-12215328-B2 | Plant-produced chimaeric orbivirus VLPs | CSIR (ZA) | 2025-02-04 | — | — | US | disclosed |
| CN-118557699-A | Antiviral compositions and methods | 莫尔豪斯医学院 | 2024-08-30 | — | — | CN | disclosed |
| CN-113194979-B | Antiviral compositions and methods | 莫尔豪斯医学院 | 2024-05-24 | — | — | CN | disclosed |
| CN-116187757-A | Complex risk calculation method and dynamic control system for coal chemical looping gasification | 青岛科技大学 | 2023-05-30 | — | — | CN | disclosed |
| CN-115997297-A | Method for manufacturing a porous electrode and battery comprising such an electrode | I-TEN公司 | 2023-04-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | DHFR, CCNH, ODC1 | CDK5 1692/4885CDK5R1 3280/4885CCNA2 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.